Skip to main content
Premium Trial:

Request an Annual Quote

Namocell, OLS OMNI Life Science Sign European Distribution Agreement

NEW YORK – Namocell said on Thursday that it has signed an agreement with Germany-based manufacturer OLS OMNI Life Science to distribute Namocell's Single Cell Dispensers in Germany and Austria.

NamoCell's microfluidic-based cell platform dispenses single cells into a 96-well plate in less than a minute.

Financial details of the agreement were not disclosed.

Namocell's "single cell isolation instruments are a game-changer for cell line engineering and development, CRISPR, single-cell genomics, antibody development and other single-cell applications," Andreas Friese, chief operating officer of OLS, said in a statement. "We look forward to offering an expanded cell research portfolio to further strengthen our position as a partner in cell research."

Namocell previously signed an agreement with Takara Bio and HepaTx in February 2020 to apply the Single-Cell Dispenser tool for single-cell genomics for late-stage liver disease.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.